- Q1 2024 Dexcom Inc Earnings Call TranscriptApr 25, 2024$138.01 (+0.10%)Earnings
- Q4 2023 Dexcom Inc Earnings Call TranscriptFeb 08, 2024$127.05 (+0.35%)Earnings
- Dexcom Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Dexcom Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Q3 2023 Dexcom Inc Earnings Call TranscriptOct 26, 2023$81.09 (-3.86%)Earnings
- Dexcom Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2023
- Dexcom Inc at Wells Fargo Healthcare Conference TranscriptSep 06, 2023
- Q2 2023 Dexcom Inc Earnings Call TranscriptJul 27, 2023$129.36 (-1.02%)Earnings
- Dexcom Inc Investor Day TranscriptJun 23, 2023
- Dexcom Inc at William Blair Growth Stock Conference TranscriptJun 07, 2023
- Q1 2023 Dexcom Inc Earnings Call TranscriptApr 27, 2023$123.58 (-1.08%)Earnings
- Dexcom Inc at Raymond James Institutional Investors Conference TranscriptMar 07, 2023
- Dexcom Inc at Citi Healthcare & Medtech Conference TranscriptMar 01, 2023
- Q4 2022 Dexcom Inc Earnings Call TranscriptFeb 09, 2023$107.24 (-2.37%)Earnings
- Dexcom Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Dexcom Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Q3 2022 Dexcom Inc Earnings Call TranscriptOct 27, 2022$101.25 (-1.33%)Earnings
- Dexcom Inc at Robert W Baird Global Healthcare Conference TranscriptSep 14, 2022
- Dexcom Inc at Wells Fargo Healthcare Conference TranscriptSep 07, 2022
- Dexcom Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2022
- Q2 2022 Dexcom Inc Earnings Call TranscriptJul 28, 2022$86.99 (+1.39%)Earnings
- Dexcom Inc at William Blair Growth Stock Conference TranscriptJun 08, 2022
- Dexcom Inc at Piper Sandler Ophthalmology and Diabetes Symposium (Virtual) TranscriptMay 25, 2022
- Dexcom Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Dexcom Inc Earnings Call TranscriptApr 28, 2022$103.31 (+0.05%)Earnings
- Dexcom Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 23, 2022
- Dexcom Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 16, 2022
- Q4 2021 Dexcom Inc Earnings Call TranscriptFeb 10, 2022$110.57 (-1.25%)Earnings
- Dexcom Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Dexcom Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 01, 2021
- Q3 2021 Dexcom Inc Earnings Call TranscriptOct 28, 2021$142.58 (+2.11%)Earnings
- Dexcom Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Dexcom Inc at Wells Fargo Virtual Healthcare Conference TranscriptSep 10, 2021
- Q2 2021 Dexcom Inc Earnings Call TranscriptJul 29, 2021$114.01 (-0.84%)Earnings
- Dexcom Inc at William Blair Growth Stock Conference (Virtual) TranscriptJun 01, 2021
- Q1 2021 Dexcom Inc Earnings Call TranscriptApr 29, 2021$105.43 (-0.96%)Earnings
- Dexcom Inc at Raymond James Institutional Investors Conference (Virtual) TranscriptMar 01, 2021
- Dexcom Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Dexcom Inc at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference TranscriptFeb 24, 2021
- Q4 2020 DexCom Inc Earnings Call TranscriptFeb 11, 2021$102.55 (+2.69%)Earnings
- DexCom Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- DexCom Inc Investor Day TranscriptDec 09, 2020
- DexCom Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 01, 2020
- DexCom Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- Q3 2020 DexCom Inc Earnings Call TranscriptOct 27, 2020$95.16 (-8.94%)Earnings
- DexCom Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- DexCom Inc at Wells Fargo Virtual Healthcare Conference TranscriptSep 10, 2020
- DexCom Inc at Robert W Baird Global Healthcare Conference TranscriptSep 09, 2020
- DexCom Inc at Canaccord Genuity Growth Conference (Virtual) TranscriptAug 12, 2020
- Q2 2020 DexCom Inc Earnings Call TranscriptJul 28, 2020$104.45 (-1.33%)Earnings
- DexCom Inc at William Blair Growth Stock Conference TranscriptJun 09, 2020
- Q1 2020 DexCom Inc Earnings Call TranscriptApr 28, 2020$78.38 (-6.42%)Earnings
- DexCom Inc at Cowen HealthCare Conference TranscriptMar 02, 2020
- Q4 2019 DexCom Inc Earnings Call TranscriptFeb 13, 2020$63.05 (+2.52%)Earnings
- DexCom Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- DexCom Inc at Piper Jaffray Healthcare Conference TranscriptDec 04, 2019
- DexCom Inc at Stephens Investor Conference TranscriptNov 13, 2019
- Q3 2019 DexCom Inc Earnings Call TranscriptNov 06, 2019$38.28 (-0.29%)Earnings
- DexCom Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- DexCom Inc at Canaccord Genuity Growth Conference TranscriptAug 07, 2019
- Q2 2019 DexCom Inc Earnings Call TranscriptJul 31, 2019$39.22 (+0.31%)Earnings
- DexCom Inc at William Blair Growth Stock Conference TranscriptJun 05, 2019
- Q1 2019 DexCom Inc Earnings Call TranscriptMay 01, 2019$29.66 (-2.02%)Earnings
- DexCom Inc at Raymond James Institutional Investors Conference TranscriptMar 04, 2019
- Q4 2018 DexCom Inc Earnings Call TranscriptFeb 21, 2019$36.56 (+0.49%)Earnings
DexCom Inc at Canaccord Genuity Growth Conference Transcript
Great. So we're going to continue on with the MedTech team here. I want to thank everybody for joining us again. This is 39th installment of Canaccord's Global Growth Conference. I appreciate everyone's participation.
I'm Kyle Rose. I'm one of the MedTech analysts here at Canaccord. I covered the diabetes space. We're very excited to have with us DexCom this afternoon. DexCom is a leader in the glucose-monitoring segment of the diabetes space with what we view as really the best-in-class technology. So very excited to have with us Steve Pacelli, the Executive Vice President of Strategy and Corporate Development as well as Quentin Blackford, the CFO.
There's a lot going on in diabetes. And I think it's a very compelling space. Valuations are -- if there's not a lot of volatility, valuation are stretched. But when I take a step back and I look at the underlying fundaments of the market, and they've never been stronger, both patient additions and then also your underlying technology. So I think there's a lot
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)